Amplification of RAC1 (Ras-related C3 botulinum toxin substrate 1) has been shown to promote cancer metastasis, invasion, migration, epithelial to mesenchymal transition (EMT), angiogenesis, cell cycle progression and drug resistance 16. Here, RAC1 is linked to cancer.